share_log

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.

NLS Pharmaceutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

NLS Pharmaceutics | SC 13G:超過5%持股股東披露文件
美股sec公告 ·  03/27 19:40
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息